Serum tumor markers, such as carcinoembryonic antigen (CEA) and carbohydrate antigen 19-9 (CA19-9), have long been used in CRC detection and monitoring [8, 9]. The gene discussed is CEACAM5; the disease is colorectal carcinoma.